UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

CONTRA: copy number analysis for targeted resequencing

Bioinformatics (Oxford, England), 2012-05, Vol.28 (10), p.1307-1313

2012

Volltextzugriff (PDF)

Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma

Clinical cancer research, 2018-12, Vol.24 (23), p.5873-5882

2018

Volltextzugriff (PDF)

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

Clinical cancer research, 2008-08, Vol.14 (16), p.5198-5208

2008

Volltextzugriff (PDF)

Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC

Cancer Immunology, Immunotherapy, 2018-03, Vol.67 (3), p.341-351

2018

Volltextzugriff (PDF)

Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells

Genome research, 2011-10, Vol.21 (10), p.1601

2011

Volltextzugriff (PDF)

Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles

PLoS genetics, 2012-09, Vol.8 (9), p.e1002894

2012

Volltextzugriff (PDF)

Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment

Nature communications, 2022-10, Vol.13 (1), p.6262-6262, Article 6262

2022

Volltextzugriff (PDF)

Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion

The Journal of clinical investigation, 2019-05, Vol.129 (5), p.1940-1945

2019

Volltextzugriff (PDF)

A Signature Predicting Poor Prognosis in Gastric and Ovarian Cancer Represents a Coordinated Macrophage and Stromal Response

Clinical cancer research, 2014-05, Vol.20 (10), p.2761-2772

2014

Volltextzugriff (PDF)

BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members

Molecular cancer therapeutics, 2016-09, Vol.15 (9), p.2030-2041

2016

Volltextzugriff (PDF)

CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence

EBioMedicine, 2020-11, Vol.61, p.103030-103030, Article 103030

2020

Volltextzugriff (PDF)

The genomic landscape of phaeochromocytoma

The Journal of pathology, 2015-05, Vol.236 (1), p.78-89

2015

Volltextzugriff (PDF)

TERT structural rearrangements in metastatic pheochromocytomas

Endocrine-related cancer, 2018-01, Vol.25 (1), p.1-9

2018

Volltextzugriff (PDF)

Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment

Nature communications, 2023-01, Vol.14 (1), p.123-123, Article 123

2023

Volltextzugriff (PDF)

Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene

Nature communications, 2017-03, Vol.8 (1), p.14581-14581, Article 14581

2017

Volltextzugriff (PDF)

Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma

The journal of clinical endocrinology and metabolism, 2016-03, Vol.101 (3), p.1034-1043

2016

Volltextzugriff (PDF)

Cohesin Rad21 mediates loss of heterozygosity and is upregulated via Wnt promoting transcriptional dysregulation in gastrointestinal tumors

Cell reports (Cambridge), 2014-12, Vol.9 (5), p.1781-1797

2014

Volltextzugriff (PDF)

Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late

Diagnostics (Basel), 2021-01, Vol.11 (1), p.103

2021

Volltextzugriff (PDF)

Options available--from start to finish--for obtaining data from DNA microarrays II

Nature genetics, 2002-12, Vol.32 Suppl (4s), p.481-489

2002

Volltextzugriff (PDF)

Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment

PloS one, 2014-04, Vol.9 (4), p.e95217-e95217

2014

Volltextzugriff (PDF)

Enhancing the anti-tumour activity of 177Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARP

Scientific reports, 2020-06, Vol.10 (1), p.10196-10196, Article 10196

2020

Volltextzugriff (PDF)

Molecular and genomic characterisation of a panel of human anal cancer cell lines

Cell death & disease, 2021-10, Vol.12 (11), p.959-15, Article 959

2021

Volltextzugriff (PDF)

Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue

Genome medicine, 2016-11, Vol.8 (1), p.121-121, Article 121

2016

Volltextzugriff (PDF)

Next-generation sequence analysis of cancer xenograft models

PloS one, 2013-09, Vol.8 (9), p.e74432-e74432

2013

Volltextzugriff (PDF)

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

Cancer research (Chicago, Ill.), 2005-05, Vol.65 (10), p.4031-4040

2005

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CONTRA: copy number analysis for targeted resequencing

Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell Carcinoma

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC

Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells

Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles

Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment

Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion

A Signature Predicting Poor Prognosis in Gastric and Ovarian Cancer Represents a Coordinated Macrophage and Stromal Response

BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members

CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence

The genomic landscape of phaeochromocytoma

TERT structural rearrangements in metastatic pheochromocytomas

Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment

Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene

Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma

Cohesin Rad21 mediates loss of heterozygosity and is upregulated via Wnt promoting transcriptional dysregulation in gastrointestinal tumors

Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late

Options available--from start to finish--for obtaining data from DNA microarrays II

Bioinformatics pipelines for targeted resequencing and whole-exome sequencing of human and mouse genomes: a virtual appliance approach for instant deployment

Enhancing the anti-tumour activity of 177Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARP

Molecular and genomic characterisation of a panel of human anal cancer cell lines

Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue

Next-generation sequence analysis of cancer xenograft models

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

Suchergebnisse filtern